<PAGE>
--------------------------------
OMB APPROVAL
--------------------------------
OMB Number: 3235-0145
Expires: August 31, 1999
Estimated average burden
hours per response.....14.90
--------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Schein Pharmaceutical, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
806416103
------------------------------
(CUSIP Number)
Marvin H. Schein
137 Commercial Street
Plainview, New York 11803
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
Copies to:
Christopher E. Manno, Esq.
Willkie Farr & Gallagher
787 Seventh Avenue
New York, NY 10019-6099
(212) 728-8000
March 13, 2000
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following: [ ]
- --------------------------------------------------------------------------------
<PAGE>
- ------------------- ------------------
CUSIP No. 806416103 13D Page 2 of 27 Pages
- ------------------- ------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Trust Created by Marvin H. Schein u/i/d September 9, 1994
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
1,007,606
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 1,007,606
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- ------------------
CUSIP No. 806416103 13D Page 3 of 27 Pages
- ------------------- ------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Trust Created by Marvin H. Schein u/i/d April 5, 1996
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
388,455
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 388,455
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- ------------------
CUSIP No. 806416103 13D Page 4 of 27 Pages
- ------------------- ------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Trust Created by Marvin H. Schein u/i/d April 9, 1997
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
2,075,276
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 2,075,276
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- ------------------
CUSIP No. 806416103 13D Page 5 of 27 Pages
- ------------------- ------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Trust Created by Marvin H. Schein u/i/d October 8, 1998
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
2,469,508
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 2,469,508
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- ------------------
CUSIP No. 806416103 13D Page 6 of 27 Pages
- ------------------- ------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Trust Created by Marvin H. Schein u/i/d December 22, 1998
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
147,816
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 147,816
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- ------------------
CUSIP No. 806416103 13D Page 7 of 27 Pages
- ------------------- ------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Marvin H. Schein, Individually and as Trustee
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
3,163,449
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 6,088,661
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 3,163,449
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
6,088,661
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- ------------------
CUSIP No. 806416103 13D Page 8 of 27 Pages
- ------------------- ------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Leslie J. Levine, as Trustee
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
-0-
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 6,088,661
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH -0-
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
6,088,661
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- ------------------
CUSIP No. 806416103 13D Page 9 of 27 Pages
- ------------------- ------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
U/A dated October 26, 1994, Pamela M. Schein as grantor
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
6,636,210
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 6,636,210
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- -------------------
CUSIP No. 806416103 13D Page 10 of 27 Pages
- ------------------- -------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Judith Shafran and Irving Shafran as Trustees U/A dated October 26,
1994, Pamela Schein as grantor
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
-0-
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 6,636,210
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH -0-
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
6,636,210
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- -------------------
CUSIP No. 806416103 13D Page 11 of 27 Pages
- ------------------- -------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Pamela M. Schein Issue Trust, dated September 29, 1994
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
508,200
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 508,200
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- -------------------
CUSIP No. 806416103 13D Page 12 of 27 Pages
- ------------------- -------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert D. Villency and Irving Shafran as Trustees for The Pamela M.
Schein Issue Trust, dated September 29, 1994
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
-0-
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 508,200
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH -0-
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
508,200
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
- ------------------- -------------------
CUSIP No. 806416103 13D Page 13 of 27 Pages
- ------------------- -------------------
- ---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Pamela M. Schein, as grantor of U/A dated October 26, 1994 and
grantor of The Pamela M. Schein Issue Trust, dated September 29, 1994
- ---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- ---------- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- -------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
7,144,410
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH ------ ----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 7,144,410
------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,396,520
- ---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
- ---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.2%
- ---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
This Schedule 13D is being filed on behalf of the Trust Created by Marvin
H. Schein u/i/d September 9, 1994, the Trust Created by Marvin H. Schein u/i/d
April 5, 1996, the Trust Created by Marvin H. Schein u/i/d April 9, 1997, the
Trust Created by Marvin H. Schein u/i/d October 8, 1998, the Trust Created by
Marvin H. Schein u/i/d December 22, 1998 (together, the "Marvin Schein Trusts"),
Marvin H. Schein, individually and as trustee of the Marvin Schein Trusts,
Leslie J. Levine, as trustee of the Marvin Schein Trusts (together with Marvin
Schein and the Marvin Schein Trusts, the "Marvin Schein Reporting Entities"),
U/A dated October 26, 1994, Pamela M. Schein as grantor ("Pamela Schein Trust
I"), the Pamela M. Schein Issue Trust, dated September 29, 1994 ("Pamela Schein
Trust II" and, together with Pamela Schein Trust I, the "Pamela Schein Trusts"),
Judith Shafran and Irving Shafran, as trustees of Pamela Schein Trust I, Robert
D. Villency and Irving Shafran, as trustees of Pamela Schein Trust II and Pamela
M. Schein, as grantor of the Pamela Schein Trusts (Mrs. Shafran, Mr. Shafran,
Ms. Schein and Mr. Villency, collectively with the Pamela Schein Trusts, the
"Pamela Schein Reporting Entities"). The Marvin Schein Reporting Entities
together with the Pamela Schein Reporting Entities are referred to herein as the
"Reporting Entities."
This Schedule 13D relates to the common stock, par value $.01 per share, of
Schein Pharmaceutical, Inc., a Delaware corporation (the "Company"). Unless the
context otherwise
Page 14 of 27 Pages
<PAGE>
requires, references herein to the "Common Stock" are to the common stock of the
Company, par value $.01 per share.
The initial acquisition of the Common Stock by the Marvin Schein Reporting
Entities was reported on Schedule 13G, filed with the Securities and Exchange
Commission (the "Commission") on February 2, 1999. The initial acquisition of
the Common Stock by the Mr. Shafran, Mrs. Shafran and Mr. Villency was reported
on Schedule 13G, filed with the Commission on August 3, 1998.
Item 1. Security and Issuer.
This statement on Schedule 13D relates to the Common Stock of the Company,
and is being filed pursuant to Rule 13d-1 under the Securities Exchange Act of
1934, as amended (the "Exchange Act"). The address of the principal executive
offices of the Company is 100 Campus Drive, Florham Park, New Jersey 07932. Item
2. Identity and Background.
(a) This statement is filed by the Reporting Entities.
(b) The business address of the Marvin H. Schein is 137 Commercial Street,
Plainview, New York 11803.
The business address of each of Leslie J. Levine and the Marvin Schein
Trusts is c/o Ackerman, Levine, Cullen & Brickman LLP, 175 Great Neck Road,
Great Neck, New York 11021.
The business address of Irving Shafran is 805 Third Avenue, Sixth Floor,
New York, New York 10022.
The business address of Judith Shafran is c/o Irving Shafran, 805 Third
Avenue, Sixth Floor, New York, New York 10022.
Page 15 of 27 Pages
<PAGE>
The business address of Robert D. Villency is 200 Madison Avenue, Mezzanine
Level, New York, New York 10016.
The business address of Pamela M. Schein is 140 West 57th Street, Ninth
Floor, New York, New York 10019.
The business address of the Pamela Schein Trusts is c/o Willkie Farr &
Gallagher, 787 Seventh Avenue, New York, New York 10019.
(c) Mr. Schein's principal occupation is as manager of his personal
investments. His principal business address is c/o Henry Schein, Inc., 135
Duryea Road, Melville, New York 11747.
Mr. Levine's principal occupation is as a partner in the law firm of
Ackerman, Levine & Cullen LLP, located at 175 Great Neck Road, Great Neck, New
York 11021.
Mr. Shafran's principal occupation is as an attorney in private practice.
His principal business address is 805 Third Avenue, Sixth Floor, New York, New
York 10022. Mr. Irving is co-trustee of the Pamela Schein Trusts.
Mrs. Shafran is retired. Mrs. Shafran is co-trustee of Pamela Schein Trust
I.
Mr. Villency's principal occupation is as chairman of Maurice Villency,
Inc., a retail furniture business that has stores in the New York metropolitan
area. The business address of Maurice Villency, Inc. is 200 Madison Avenue, New
York, New York 10016. Since 1974, Mr. Villency has been Chief Executive Officer
of Roche Bobois USA., Ltd., a franchisor of retail stores selling imported
Page 16 of 27 Pages
<PAGE>
furniture. The business address of Roche Bobois USA., Ltd. is 200 Madison
Avenue, New York, New York 10016. Mr. Villency is co-trustee of Pamela Schein
Trust II.
Pamela M. Schein's principal occupation is editorial director of Madison
Magazine. The business address of Madison Magazine is 140 West 57th Street,
Ninth Floor, New York, New York 10019.
The Marvin Schein Trusts and the Pamela Schein Trusts were established for
the benefit of various family members of Marvin H. Schein and Pamela M. Schein
and certain charitable institutions.
(d) None of the Reporting Entities has, during the last five years, been
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) None of the Reporting Entities has, during the last five years, been a
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
(f) Each of Mr. Schein, Mr. Levine, Mr. Shafran, Mrs. Shafran, Mr. Villency
and Ms. Schein is a United States citizen. Each of the Marvin Schein Trusts and
the Pamela Schein Trusts are trusts created in the United States.
Page 17 of 27 Pages
<PAGE>
Item 3. Source and Amount of Funds or Other
- ------ -----------------------------------
Consideration:
-------------
The securities of the Company described herein were acquired as a result of
the initial public offering of the Company pursuant to a registration statement
on Form S-1 under the Securities Act of 1933, as amended, filed with the
Commission on April 8, 1998. Pursuant to the understanding between the Reporting
Entities discussed below in Item 4, the Reporting Entities may be deemed to have
acquired beneficial ownership of each of the other Reporting Entities shares of
Common Stock under Rule 13d-5(b) of the Exchange Act.
Item 4. Purpose of Transaction:
- ------ ----------------------
On September 30, 1994, the Reporting Entities entered into a Voting Trust
Agreement (the "Voting Trust Agreement") pursuant to which the Reporting
Entities granted Martin Sperber, Chairman and Chief Executive Officer of the
Company, the authority to vote all of the shares of Common Stock beneficially
held by the Reporting Entities. On March 1, 2000 the Voting Trust Agreement
expired pursuant to its terms and, consequently, as of the date of this filing,
the Reporting Entities possess full power and authority to vote the shares of
Common Stock beneficially held by each of them as disclosed herein.
On January 25, 2000, the Company issued a press release announcing the
retention of certain financial advisors to explore strategic alternatives for
the Company, including the possible sale
Page 18 of 27 Pages
<PAGE>
of the Company. The Company noted that it had been exploring opportunities to
enhance the value of its businesses over the previous several months.
The Reporting Entities note the Company's efforts as reflected in the
January 25, 2000 press release and currently have no plans or proposals which
would result in frustrating or impeding the Company's actions in connection with
the exploration of strategic alternatives. The Reporting Entities fully endorse
the pursuit of a strategic transaction that will lead to the sale of the
Company.
Notwithstanding the above, in order to reserve their rights under Section
14 of the Exchange Act (and the rules promulgated thereunder), on March 13,
2000, pursuant to requirements under the Company's By-laws, the Reporting
Entities sent a Notice of Nominations of Persons for Election to the Board of
Directors of Schein Pharmaceutical, Inc. and Amendments to the By-Laws of Schein
Pharmaceutical, Inc. (the "Notice") to the Secretary of Company proposing that
the Company's Notice of Annual Meeting for the Company's 2000 Annual Meeting of
Stockholders include the nominations of Marvin H. Schein and Irving Shafran as
directors of the Company with terms expiring in 2003, the presentation of
certain amendments to the Company's By-laws and the nominations of Leslie J.
Levine and Robert D. Villency to fill the new directorships that would be
created by such amendments to the By-laws, if adopted.
In addition, the Notice indicates that the Reporting Entities have entered
into an understanding to vote all the shares
Page 19 of 27 Pages
<PAGE>
over which any of them has voting control in favor of all of the proposals and
for the election of all the nominees set forth in the Notice.
On March 28, 2000 the Reporting Entities sent an Amendment to Notice of
Nominations of Persons for Election to the Board of Directors of Schein
Pharmaceutical, Inc. and Amendments to the By-Laws of Schein Pharmaceutical,
Inc. (the "Amended Notice") to the Secretary of Company to correct the number of
shares of Common Stock over which the Reporting Entities have voting control.
The descriptions of the Notice and the Amended Notice in this Item 4 are
qualified in their entirety by reference to the Notice and the Amended Notice,
which are attached hereto as Exhibit 2 and Exhibit 3, respectively, and are
incorporated by reference herein.
Except as set forth above, the Reporting Entities do not have any plans or
proposals which relate to or would result in: (a) the acquisition by any person
of additional securities of the Company, or the disposition of securities of the
Company; (b) an extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Company or any of its subsidiaries;
(c) a sale or transfer of a material amount of assets of the Company or any of
its subsidiaries; (d) any change in the present Board of Directors or management
of the Company, including any plans or proposals to change the number or term of
directors or to fill any existing vacancies on the board; (e) any material
Page 20 of 27 Pages
<PAGE>
change in the present capitalization or dividend policy of the Company; (f) any
other material change in the Company's business or corporate structure; (g)
changes in the Company's charter, By-laws or instruments corresponding thereto
or other actions which may impede the acquisition of control of the Company by
any person; (h) causing a class of securities of the Company to be delisted from
a national securities exchange or to cease to be authorized to be quoted in an
inter-dealer quotation system of a registered national securities association;
(i) a class of equity securities of the Company becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or
(j) any action similar to any of those enumerated above.
Item 5. Interest in Securities of the Issuer:
- ------- ------------------------------------
(a)
<TABLE>
<CAPTION>
Number Percentage
<S> <C> <C>
Trust Created by Marvin H. Schein 1,007,606(1) 3.1%(2)
u/i/d September 9, 1994
Trust Created by Marvin H. Schein 388,455(1) 1.2%(2)
u/i/d
April 5, 1996
Trust Created by Marvin H. Schein 2,075,276(1) 6.3%(2)
u/i/d
April 9, 1997
Trust Created by Marvin H. Schein 2,469,508(1) 7.6%(2)
u/i/d
October 8, 1998
Trust Created by Marvin H. Schein 147,816(1) .45%(2)
u/i/d
December 22, 1998
Marvin H. Schein, individually and as 9,252,110(1) 28.3%(2)
trustee of each of the Marvin Schein
Trusts
Leslie J. Levine, as trustee of each 6,088,661(1) 18.0%(2)
of the Marvin Schein Trusts
Page 21 of 27 Pages
<PAGE>
U/A dated October 26, 1994, Pamela M. 6,636,210(1) 18.6%(2)
Schein as grantor
Pamela M. Schein Issue Trust, dated 508,200(1) 1.6%(2)
September 29, 1994
Judith Shafran and Irving Shafran, as 6,636,210(1) 20.3%(2)
trustees of U/A dated October 26, 1994,
Pamela M. Schein as grantor
Robert D. Villency and Irving Shafran, 508,200(1) 1.6%(2)
as trustees of The Pamela M. Schein
Issue Trust, dated September 29, 1994
Pamela Schein, as grantor of U/A dated 7,144,410(1)(3) 21.9%(2)(3)
October 26, 1994 and as grantor of The
Pamela Schein Issue Trust, dated
September 29, 1994(3)
(1) Pursuant to Rule 13d-5(b) under the Exchange Act, each of the Reporting
Entities may be deemed to beneficially own 16,396,520 shares of Common
Stock.
(2) Pursuant to Rule 13d-5(b) under the Exchange Act, each of the Reporting
Entities may be deemed to beneficially own 50.2% of the shares of Common
Stock.
(3) As grantor of the Pamela Schein Trusts, Pamela Schein has the power to
revoke such trusts and consequently may be deemed to beneficially own the
shares of Common Stock held by such trusts.
</TABLE>
(b)
<TABLE>
<CAPTION>
Sole Voting Shared Voting Sole Dispositive Shared
Power Power Power Dispositive Power
<S> <C> <C> <C> <C>
Trust Created by Marvin H. 1,007,606 -0- 1,007,606 -0-
Schein u/i/d
September 9, 1994
Trust Created by Marvin H. 388,455 -0- 388,455 -0-
Schein u/i/d
April 5, 1996
Trust Created by Marvin H. 2,075,276 -0- 2,075,276 -0-
Schein u/i/d
April 9, 1997
Trust Created by Marvin H. 2,469,508 -0- 2,469,508 -0-
Schein u/i/d
October 8, 1998
Trust Created by Marvin H. 147,816 -0- 147,816 -0-
Schein u/i/d
December 22, 1998
Page 22 of 27 Pages
<PAGE>
Marvin H. Schein, individually -0- 9,252,110 -0- 9,252,110
and as trustee of each of the
Marvin Schein Trusts
Leslie J. Levine, as trustee of -0- 6,088,661 -0- 6,088,661
each of the Marvin Schein Trusts
U/A dated October 26, 1994, 6,636,210 -0- 6,636,210 -0-
Pamela M. Schein as grantor
Pamela M. Schein Issue Trust, 508,200 -0- 508,200 -0-
dated September 29, 1994
Judith Shafran and Irving -0- 6,636,210 -0- 6,636,210
Shafran, as
trustees U/A dated October 26,
1994,
Pamela M. Schein as grantor
Robert D. Villency and Irving -0- 508,200 -0- 508,200
Shafran,
as trustees of The Pamela M.
Schein Issue
Trust, dated September 29, 1994
Pamela M. Schein, as grantor of 7,144,410 -0- 7,144,410 -0-
U/A dated October 26, 1994 and
as grantor of The Pamela M.
Schein Issue Trust, dated
September 29, 1994
</TABLE>
(c) During the last sixty days there were no transactions effected by the
Reporting Entities, except for a purchase of ten (10) shares of common stock by
Marvin H. Schein in the open market on March 2, 2000 at a price per share of
$12.937.
(d) Not Applicable
(e) Not Applicable
Item 6. Contracts, Arrangements, Understandings or
- ------- ------------------------------------------
Relationships with Respect to Securities of the
-----------------------------------------------
Issuer:
-------
Pursuant to Rule 13d-1(k) promulgated under the Exchange Act, the Reporting
Entities have entered into an agreement with respect to the joint filing of this
statement, and any amendment or amendments hereto (the "Joint Filing
Agreement"). The Joint Filing Agreement is attached hereto as Exhibit 1 to this
Schedule 13D.
Page 23 of 27 Pages
<PAGE>
By virtue of the relationships and understandings among the Reporting
Entities as described in Item 4, the Reporting Entities may be deemed to be a
"group" under the Federal securities laws.
Except as referred to above and in Item 4 of this Schedule 13D, there are
no contracts, arrangements, understandings or relationships among the persons
named in Item 2 or between such persons and any other person with respect to any
securities of the Company.
Item 7. Material to Be Filed as Exhibits:
- ------- --------------------------------
1. Joint Filing Agreement, dated as of March 28, 2000, by and among the
Reporting Entities.
2. Notice of Nominations of Persons for Election to the Board of Directors
of Schein Pharmaceutical, Inc. and Amendments to the By-laws of Schein
Pharmaceutical, Inc., dated March 13, 2000.
3. Amendment to Notice of Nominations of Persons for Election to the Board
of Directors of Schein Pharmaceutical, Inc. and Amendments to the By-laws of
Schein Pharmaceutical, Inc., dated March 28, 2000.
Page 24 of 27 Pages
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: March 28, 2000
By: /s/ Marvin H. Schein
------------------------------
Name: Marvin H. Schein
Title: Individually and as
Trustee for:
Trust Created by Marvin H. Schein
u/i/d September 9, 1994
Trust Created by Marvin H. Schein
u/i/d April 5, 1996
Trust Created by Marvin H. Schein
u/i/d April 9, 1997
Trust Created by Marvin H. Schein
u/i/d October 8, 1998
Trust Created by Marvin H. Schein
u/i/d December 22, 1998
By: /s/ Leslie J. Levine
------------------------------
Name: Leslie J. Levine
Title: Trustee for:
Trust Created by Marvin H. Schein
u/i/d September 9, 1994
Trust Created by Marvin H. Schein
u/i/d April 5, 1996
Trust Created by Marvin H. Schein
u/i/d April 9, 1997
Trust Created by Marvin H. Schein
u/i/d October 8, 1998
Trust Created by Marvin H. Schein
u/i/d December 22, 1998
Page 25 of 27 Pages
<PAGE>
By: /s/ Irving Shafran
------------------------------
Name: Irving Shafran
Title: Trustee for U/A dated
October 26, 1994, Pamela
M. Schein as grantor;
Trustee for the Pamela M.
Schein Issue Trust, dated
September 29, 1994
By: /s/ Judith Shafran
------------------------------
Name: Judith Shafran
Title: Trustee for U/A dated
October 26, 1994, Pamela
M. Schein as grantor
By: /s/ Robert D. Villency
------------------------------
Name: Robert D. Villency
Title: Trustee for the Pamela M.
Schein Issue Trust dated
September 29, 1994
By: /s/ Pamela M. Schein
------------------------------
Name: Pamela M. Schein
Title: Grantor of U/A dated
October 26, 1994; Grantor of
the Pamela M. Schein Issue
Trust dated September
29, 1994
Page 26 of 27 Pages
<PAGE>
EXHIBITS
Exhibit 1 Joint Filing Agreement, dated March 28, 2000, among the
signatories to this Schedule 13D.
Exhibit 2 Notice of Nominations of Persons for Election to the Board
of Directors of Schein Pharmaceutical, Inc. and Amendments
to the By-laws of Schein Pharmaceutical, Inc., dated March
13, 2000.
Exhibit 3 Amendment to Notice of Nominations of Persons for Election
to the Board of Directors of Schein Pharmaceutical, Inc. and
Amendments to the By-laws of Schein Pharmaceutical, Inc.,
dated March 28, 2000.
Page 27 of 27 Pages
<PAGE>
Exhibit 1
JOINT FILING AGREEMENT
PURSUANT TO RULE 13d-1(k)(1)
----------------------------
The undersigned acknowledge and agree that the foregoing statement on
Schedule 13D is filed on behalf of each of the undersigned and that all
subsequent amendments to this statement on Schedule 13D shall be filed on behalf
of each of the undersigned pursuant to and in accordance with the provisions of
Rule 13d-1(k) under the Securities Exchange Act of 1934 without the necessity of
filing additional joint filing agreements. This Agreement may be executed in any
number of counterparts and all of such counterparts taken together shall
constitute one and the same instrument.
Dated: March 28, 2000
By: /s/ Marvin H. Schein
------------------------------
Name: Marvin H. Schein
Title: Individually and as
Trustee for:
Trust Created by Marvin H. Schein
u/i/d September 9, 1994
Trust Created by Marvin H. Schein
u/i/d April 5, 1996
Trust Created by Marvin H. Schein
u/i/d April 9, 1997
Trust Created by Marvin H. Schein
u/i/d October 8, 1998
Trust Created by Marvin H. Schein
u/i/d December 22, 1998
By: /s/ Leslie J. Levine
------------------------------
Name: Leslie J. Levine
Title: Trustee for:
Trust Created by Marvin H. Schein
u/i/d September 9, 1994
Trust Created by Marvin H. Schein
u/i/d April 5, 1996
<PAGE>
Trust Created by Marvin H. Schein
u/i/d April 9, 1997
Trust Created by Marvin H. Schein
u/i/d October 8, 1998
Trust Created by Marvin H. Schein
u/i/d December 22, 1998
By: /s/ Irving Shafran
------------------------------
Name: Irving Shafran
Title: Trustee for U/A dated
October 26, 1994, Pamela
M. Schein as grantor;
Trustee for the Pamela M.
Schein Issue Trust, dated
September 29, 1994
By: /s/ Judith Shafran
------------------------------
Name: Judith Shafran
Title: Trustee for U/A dated
October 26, 1994, Pamela
M. Schein as grantor
By: /s/ Robert D. Villency
------------------------------
Name: Robert D. Villency
Title: Trustee for the Pamela M.
Schein Issue Trust dated
September 29, 1994
By: /s/ Pamela M. Schein
------------------------------
Name: Pamela M. Schein
Title: Grantor of U/A dated
October 26, 1994; Grantor of
the Pamela M. Schein Issue
Trust dated September
29, 1994
<PAGE>
NOTICE OF
NOMINATIONS OF PERSONS
FOR ELECTION TO THE BOARD OF DIRECTORS
OF
SCHEIN PHARMACEUTICAL, INC.
AND
AMENDMENTS TO THE BY-LAWS
OF
SCHEIN PHARMACEUTICAL, INC.
To the Secretary of
Schein Pharmaceutical, Inc.:
This Notice is given pursuant to Article II, Section 4 of the Amended and
Restated By-laws, and Article Sixth of the Restated Certificate of Incorporation
of Schein Pharmaceutical, Inc., a Delaware corporation (the "Corporation"). The
undersigned (the "undersigned" or "stockholders") are stockholders of record of
an aggregate of 16,196,508 shares of common stock, par value $.01 per share,
representing approximately 50% of the common stock of the Corporation on the
date hereof and intend to remain stockholders of record through the date of the
Corporation's 2000 Annual Meeting of Stockholders. The record addresses of the
undersigned are set forth below.
The proposals the undersigned or their agents intend to make are described
below. The undersigned represent that they intend to appear in person or by
proxy at the meeting to bring up the proposals included as part of this notice.
The stockholders request that the Notice of Annual Meeting include the
below proposed nominations and By-law amendments.
Dated: March 13, 2000
[SIGNATURES APPEAR ON THE NEXT PAGE]
<PAGE>
By: /s/ Irving Shafran
------------------------------
Name: Irving Shafran
Title: Trustee U/A dated October 26, 1994,
Pamela M. Schein as grantor; Trustee
of the Pamela M. Schein Issue Trust,
dated September 29, 1994
Trust Address: Trust Dated October 26, 1994,
Pamela M. Schein as grantor,
c/o Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019;
Pamela M. Schein Issue Trust,
dated September 29, 1994,
c/o Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019
By: /s/ Judith Shafran
------------------------------
Name: Irving Shafran
Title: Trustee U/A dated October 26, 1994,
Pamela M. Schein as grantor;
Trust Address:
c/o Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019
By: /s/ Robert D. Villency
------------------------------
Name: Robert D. Villency
Title: Trustee of the Pamela M. Schein Issue
Trust, dated September 29, 1994
Trust Address:
c/o Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019
-2-
<PAGE>
By: /s/ Marvin H. Schein
------------------------------
Name: Marvin H. Schein
Title: Individually and as Trustee for
Trust established by Marvin H.
Schein u/i/d 9/9/94, Trust
established by Marvin H. Schein
u/i/d 4/5/96, Trust established
by Marvin H. Schein u/i/d 4/9/97,
Trust established by Marvin H.
Schein u/i/d 10/8/98, Trust
established by Marvin H. Schein
u/i/d 12/22/98
Trust Addresses: c/o Ackerman, Levine &
Cullen, LLP
175 Great Neck Road
Great Neck, New York 11021
By: /s/ Leslie J. Levine
------------------------------
Name: Leslie J. Levine
Title: Trustee for Trust established by
Marvin H. Schein u/i/d 9/9/94,
Trust established by Marvin H.
Schein u/i/d 4/5/96, Trust
established by Marvin H. Schein
u/i/d 4/9/97, Trust established
by Marvin H. Schein u/i/d
10/8/98, Trust established by
Marvin H. Schein u/i/d 12/22/98
Trust Addresses: c/o Ackerman, Levine &
Cullen, LLP
175 Great Neck Road
Great Neck, New York 11021
-3-
<PAGE>
PROPOSAL I: Nominate two persons to be elected as directors
with term expiring 2003 to the Board of Directors
of Schein Pharmaceutical, Inc.
The stockholders propose to elect the following individuals to the Board of
Directors of Schein Pharmaceutical, Inc. as directors with term expiring 2003:
Marvin H. Schein and Irving Shafran
Information about the foregoing nominees is required to be provided pursuant to
Article Sixth of the Restated Certificate of Incorporation of Schein
Pharmaceutical, Inc. Where information sought by Schedule 14A under the
Securities Exchange Act of 1934, as amended, would be answered in the negative
and no response would be required to be included in a proxy statement, no such
response is included below.
MARVIN H. SCHEIN, age 58, founded Schein Dental Equipment Corp., a distributor
of large dental equipment, and served as its President for more than 15 years
until its sale in August 1998 to Henry Schein, Inc., a public company traded on
NASDAQ. Prior to founding Schein Dental Equipment Corp., Mr. Schein held various
management and executive positions with Henry Schein, Inc. He has served as a
director of Henry Schein, Inc. since September 1994. Since August 1998, Mr.
Schein has been engaged in the management of his personal investments.
IRVING SHAFRAN, age 55, has been a director of Henry Schein, Inc. since
September 1994 and was nominated by Pamela Schein as her designee for director
of Henry Schein, Inc. Mr. Shafran has been an attorney in private practice for
the past 25 years. From 1991 through December 1995, Mr. Shafran was a partner in
the law firm of Anderson Kill Olick and Oshinsky, PC.
Mr. Shafran, as a co-trustee of a Trust dated October 26, 1994, Pamela M. Schein
as grantor, holds approximately 20% of the common stock of the Corporation on
the date hereof. Mr. Shafran, as a co-trustee of the Pamela M. Schein Issue
Trust, dated September 29, 1994, holds approximately 1.56% of the common stock
of the Corporation on the date hereof.
Mr. Schein has established a number of trusts for the benefit of various family
members and charitable institutions of which he is a trustee. Mr. Schein has
entered into an understanding with Irving Shafran, Judith Shafran and Robert D.
Villency, trustees of certain trusts established by Pamela Schein, the niece of
Mr. Schein, that hold approximately 22% of the outstanding shares of common
stock of the Corporation, to vote all shares over which any of them has voting
control in favor of all of the proposals and for the election of all of the
nominees described in this notice.
-4-
<PAGE>
In the ordinary course of business, Schein Pharmaceutical, Inc. sells
pharmaceutical products to Henry Schein, Inc. for distribution to its customers.
Both Mssrs. Schein and Shafran are stockholders and directors of Henry Schein,
Inc.
-5-
<PAGE>
PROPOSAL II: Notification of Intent to Present Amendments to
the By-laws of Schein Pharmaceutical, Inc.
The stockholders intend to present at the Annual Meeting of Stockholders the
following resolutions to be adopted by the stockholders as amendments to the
Corporation's By-laws:
"RESOLVED, that the first sentence of Article III, Section 1 of the By-laws
of the Corporation is hereby amended to read in its entirety as follows:
'Except as may otherwise be provided in the Certificate of
Incorporation or By-laws, the business and affairs of the Corporation shall
be managed by or under the direction of a Board of Directors of nine
directors.'"
"RESOLVED, that Article III, Section 14 of the By-laws of the Corporation
is hereby amended by adding thereto the new sentence appearing in italics below.
Such section, as so amended, shall read in its entirety as follows:
'Newly created directorships resulting from an increase in the number
of directors and vacancies occurring in the Board of Directors for any
reason may be filled in a manner that does not contravene the provisions of
Section 1 of the general stockholders agreement dated September 30, 1994
among Schein Holdings, Inc., Miles, Inc. ("Miles") and certain stockholders
of Schein Holdings, Inc. (the "General Stockholders Agreement"). The
provisions of the preceding sentence may be amended only with the written
consent of Bayer Corporation ("Bayer," formerly Miles), and shall be of no
further force or effect upon the termination of Bayer's rights under
Section 1 of the General Stockholders Agreement, as provided in Section 1.5
of the General Stockholders Agreement. New directorships created by the
stockholders by amendment of the By-laws at a meeting of the stockholders
shall only be filled by the stockholders at such meeting or at any other
duly called meeting of the stockholders. A director elected to fill a
vacancy shall be elected to hold office until the next annual meeting of
stockholders at which the election of such director is in the regular order
of business and until his or her successor has been elected and
qualified.'"
-6-
<PAGE>
PROPOSAL III: Notice pursuant to Article Sixth of the
Corporation's Certificate of Incorporation
The stockholders propose to nominate the following individuals for election
to the Corporation's Board of Directors to fill the two new directorships
created by Proposal II above, should such Proposal II be adopted by the
stockholders of the Corporation:
Leslie J. Levine and Robert D. Villency
Information about the following nominees is required to be provided pursuant to
Article Sixth of the Restated Certificate of Incorporation of Schein
Pharmaceutical, Inc. Where information sought by Schedule 14A under the
Securities Exchange Act of 1934, as amended, would be answered in the negative
and no response would be required to be included in a proxy statement, no such
response is included below.
LESLIE J. LEVINE, age 56, has been a partner in the law firm of Ackerman,
Levine, Cullen & Brickman, LLP in Great Neck, New York, for more than 25 years.
ROBERT D. VILLENCY, age 61, is the chairman of Maurice Villency, Inc., a retail
furniture businesses that has stores in the New York metropolitan area. Since
1974, Mr. Villency has been the Chief Executive Officer of Roche Bobois USA.,
Ltd., a franchisor of retail stores selling imported furniture with stores
throughout the United States and Canada.
Mr. Villency, as a co-trustee of the Pamela M. Schein Issue Trust, dated
September 29, 1994, holds approximately 1.56% of the common stock of the
Corporation on the date hereof.
Marvin Schein has established a number of trusts for the benefit of various
family members and charitable institutions of which he and Mr. Levine are
trustees. Mr. Levine has entered into an understanding with Irving Shafran,
Judith Shafran and Robert D. Villency, trustees of certain trusts established by
Pamela Schein, the niece of Mr. Schein, that hold approximately 22% of the
outstanding shares of common stock of the Corporation, to vote all shares over
which any of them has voting control in favor of all of the proposals and for
the election of all of the nominees described in this notice.
-7-
<PAGE>
AMENDMENT
TO NOTICE OF
NOMINATIONS OF PERSONS
FOR ELECTION TO THE BOARD OF DIRECTORS
OF
SCHEIN PHARMACEUTICAL, INC.
AND
AMENDMENTS TO THE BY-LAWS
OF
SCHEIN PHARMACEUTICAL, INC.
To the Secretary of
Schein Pharmaceutical, Inc.:
This Amended Notice amends the Notice of Nominations of Persons for
Election to the Board of Directors of Schein Pharmaceutical, Inc. and Amendments
to the By-Laws of Schein Pharmaceutical, Inc., dated March 13, 2000 (the
"Original Notice") sent to the Secretary of Schein Pharmaceutical, Inc. on such
date.
The Original Notice is hereby amended as follows:
1. The second sentence of the first paragraph of the Original Notice is
hereby deleted in its entirety and replaced with the following:
The undersigned (the "undersigned" or "stockholders") are stockholders of
record of an aggregate of 16,396,520 shares of common stock, par value $.01 per
share, representing approximately 50% of the common stock of the Corporation on
the date hereof and intend to remain stockholders of record through the date of
the Corporation's 2000 Annual Meeting of Stockholders.
2. The following paragraph is added after the the information provided in
connection with IRVING SHAFRAN under PROPOSAL I:
Since the date of the Original Notice, it has come to the attention of the
undersigned that during the Corporation's fiscal year 1999, Mr. Shafran, in his
capacity as trustee of the Trust dated October 26, 1994 and the Pamela M. Schein
Issue Trust dated September 29, 1994, had not timely filed a Form 3 reporting
beneficial ownership of more than ten percent (10%) of the common stock of the
Corporation. Such filing is currently being made.
Dated: March 28, 2000
[SIGNATURES APPEAR ON THE NEXT PAGE]
<PAGE>
By: /s/ Irving Shafran
------------------------------
Name: Irving Shafran
Title: Trustee U/A dated October 26, 1994,
Pamela M. Schein as grantor; Trustee
of the Pamela M. Schein Issue Trust,
dated September 29, 1994
Trust Address: Trust Dated October 26, 1994,
Pamela M. Schein as grantor,
c/o Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019;
Pamela M. Schein Issue Trust,
dated September 29, 1994,
c/o Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019
By: /s/ Judith Shafran
------------------------------
Name: Judith Shafran
Title: Trustee U/A dated October 26, 1994,
Pamela M. Schein as grantor;
Trust Address:
c/o Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019
By: /s/ Robert D. Villency
------------------------------
Name: Robert D. Villency
Title: Trustee of the Pamela M. Schein Issue
Trust, dated September 29, 1994
Trust Address:
c/o Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019
-2-
<PAGE>
By: /s/ Marvin H. Schein
------------------------------
Name: Marvin H. Schein
Title: Individually and as Trustee for
Trust established by Marvin H.
Schein u/i/d 9/9/94, Trust
established by Marvin H. Schein
u/i/d 4/5/96, Trust established
by Marvin H. Schein u/i/d 4/9/97,
Trust established by Marvin H.
Schein u/i/d 10/8/98, Trust
established by Marvin H. Schein
u/i/d 12/22/98
Trust Addresses: c/o Ackerman, Levine &
Cullen, LLP
175 Great Neck Road
Great Neck, New York 11021
By: /s/ Leslie J. Levine
------------------------------
Name: Leslie J. Levine
Title: Trustee for Trust established by
Marvin H. Schein u/i/d 9/9/94,
Trust established by Marvin H.
Schein u/i/d 4/5/96, Trust
established by Marvin H. Schein
u/i/d 4/9/97, Trust established
by Marvin H. Schein u/i/d
10/8/98, Trust established by
Marvin H. Schein u/i/d 12/22/98
Trust Addresses: c/o Ackerman, Levine &
Cullen, LLP
175 Great Neck Road
Great Neck, New York 11021
-3-
